Počet záznamov: 1
merkaptopurín
SYS d015122 LBL 00000cz--a2200000n--4500 005 20250606214857.3 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D02.886.489.534 065 $a D03.633.100.759.570 066 $a 01 $c 03 150 $a merkaptopurín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a 6-Mercaptopurine $2 eng 450 $w v $a 1,7-dihydro-6H-purín-6-tion $2 slo 450 $w v $a 6-merkaptopurín $2 slo 450 $w v $a 6-merkaptopurín monohydrát $2 slo 450 $w v $a 6-tiohypoxantín $2 slo 450 $w v $a 6-tiopurín $2 slo 450 $w v $a BW 57-323H $2 slo 450 $w v $a leupurín $2 slo 450 $w v $a merkaptopurín bezvodý $2 slo 450 $w v $a purinetol $2 slo 450 $w v $a purimetol $2 slo 550 $7 sllk_us_auth*d000963 $Y Antimetabolites $w P $a antimetabolity 550 $7 sllk_us_auth*d000964 $Y Antimetabolites, Antineoplastic $w P $a antimetabolity protinádorové 550 $7 sllk_us_auth*d007166 $Y Immunosuppressive Agents $w P $a imunosupresíva 550 $7 sllk_us_auth*d019384 $Y Nucleic Acid Synthesis Inhibitors $w P $a inhibítory syntézy nukleových kyselín 665 $a 2018(1985) $2 eng 680 9-
$i An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. $2 eng 750 -2
$a Mercaptopurine $2 eng 980 $x M
Počet záznamov: 1